Developer of therapeutics products intended for fibrosis, anemia, neutropenia, cancer and autoimmune disease/inflammation as well as certain nephropathic. The company focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using a drug discovery platform and a data-driven approach, enabling the healthcare industry to get reliable medicines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.